EP2841084
CXCR4 ANTAGONIST PEPTIDE FOR USE IN THE TREATMENT OF LARGE CELL LUNG CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.4.2013EP published:
30.5.2018EP application number:
13727657.2
EPO information:
European Patent Register
Max expiry date:
23.4.2033
Title:
CXCR4 ANTAGONIST PEPTIDE FOR USE IN THE TREATMENT OF LARGE CELL LUNG CANCER
Timeline
Today
24.4.2013EP application
30.5.2018EP Publication
Owner
Name:
Biokine Therapeutics Ltd.Address:
Building 13a Einstein Street, Science Park Kiryat Weizmann, 70400, Nes Ziona, IL
Inventor
Name:
PELED, AmnonAddress:
Tel-Aviv, IL
Name:
WALD, OriAddress:
Tel-Aviv, IL
Priority
Number:
201261637334 PDate:
24.4.2012Country:
US
Classification
Categories:
A61K 38/10, A61K 31/282, A61K 31/337, A61P 35/00